Debt-to-equity in % of Tonix Pharmaceuticals Holding Corp. from Q1 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly Debt-to-equity history and change rate from Q1 2012 to Q3 2025.
  • Tonix Pharmaceuticals Holding Corp. Debt-to-equity for the quarter ending 30 Sep 2025 was 11%, a 72% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Tonix Pharmaceuticals Holding Corp. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 11% -27% -72% 30 Sep 2025
Q2 2025 14% -19% -58.6% 30 Jun 2025
Q1 2025 19% -5% -18.9% 31 Mar 2025
Q4 2024 27% +8% +45% 31 Dec 2024
Q3 2024 38% +27% +244% 30 Sep 2024
Q2 2024 33% +24% +271% 30 Jun 2024
Q1 2024 24% +16% +219% 31 Mar 2024
Q4 2023 19% +11% +155% 31 Dec 2023
Q3 2023 11% +3% +43.3% 30 Sep 2023
Q2 2023 9% +1% +12.6% 30 Jun 2023
Q1 2023 8% 0% +2.6% 31 Mar 2023
Q4 2022 7% +1% +14.8% 31 Dec 2022
Q3 2022 8% +2% +29.9% 30 Sep 2022
Q2 2022 8% +2% +28.3% 30 Jun 2022
Q1 2022 7% 0% +3.25% 31 Mar 2022
Q4 2021 6% -3% -34.5% 31 Dec 2021
Q3 2021 6% -5% -47.4% 30 Sep 2021
Q2 2021 6% -8% -57.9% 30 Jun 2021
Q1 2021 7% -13% -63.9% 31 Mar 2021
Q4 2020 10% -14% -59.1% 31 Dec 2020
Q3 2020 11% -4% -23.8% 30 Sep 2020
Q2 2020 14% +1% +4.41% 30 Jun 2020
Q1 2020 20% +6% +43.3% 31 Mar 2020
Q4 2019 24% +10% +74.1% 31 Dec 2019
Q3 2019 15% +2% +14.7% 30 Sep 2019
Q2 2019 14% +4% +36.7% 30 Jun 2019
Q1 2019 14% +6% +76.4% 31 Mar 2019
Q4 2018 14% +7% +96.3% 31 Dec 2018
Q3 2018 13% +6% +84.6% 30 Sep 2018
Q2 2018 10% +2% +28.9% 30 Jun 2018
Q1 2018 8% -3% -25.9% 31 Mar 2018
Q4 2017 7% -5% -41.4% 31 Dec 2017
Q3 2017 7% -7% -51% 30 Sep 2017
Q2 2017 8% -6% -41.7% 30 Jun 2017
Q1 2017 10% -2% -15.5% 31 Mar 2017
Q4 2016 12% +2% +16.1% 31 Dec 2016
Q3 2016 14% +5% +61.6% 30 Sep 2016
Q2 2016 13% +5% +61.2% 30 Jun 2016
Q1 2016 12% +5% +71.2% 31 Mar 2016
Q4 2015 10% +3% +50.3% 31 Dec 2015
Q3 2015 9% +1% +18.6% 30 Sep 2015
Q2 2015 8% 0% -5.33% 30 Jun 2015
Q1 2015 7% -8% -53% 31 Mar 2015
Q4 2014 7% -77% -91.9% 31 Dec 2014
Q3 2014 7% -172% -95.9% 30 Sep 2014
Q2 2014 9% +248% 30 Jun 2014
Q1 2014 15% -1115% -98.6% 31 Mar 2014
Q4 2013 84% -860% -91.1% 31 Dec 2013
Q3 2013 179% +451% 30 Sep 2013
Q2 2013 -239% +77% +24.4% 30 Jun 2013
Q1 2013 1130% +1338% 31 Mar 2013
Q4 2012 944% 31 Dec 2012
Q3 2012 -272% 30 Sep 2012
Q2 2012 -316% 30 Jun 2012
Q1 2012 -208% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.